Dow Down 0.22% Nasdaq Up 0.14%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.66 Up 0.02(1.22%) Aug 22, 4:00PM EDT
Prev Close:1.64
Open:1.63
Bid:N/A
Ask:1.69 x 25000
1y Target Est:4.17
Beta:0.6
Earnings Date:Sep 8 - Sep 12 (Est.)
Day's Range:1.61 - 1.67
52wk Range:1.16 - 3.18
Volume:473,409
Avg Vol (3m):1,149,630
Market Cap:297.49M
P/E (ttm):N/A
EPS (ttm):-0.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PPHM

Comparison

Symbol% ChgMkt Cap
PPHMUp 1.22%297.49M
AMGNUp 0.22%100.89B
NVS 0.00%215.81B
RHHBYDown 0.33%246.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.12
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Apr-15) :-0.27
Quarterly EPS Est (Jul-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the research and development of novel monoclonal antibodies for the treatment and diagnosis of cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback